NetFlix Inc vs Nuwellis Inc — how do they compare? NetFlix Inc trades at $74.57 (market cap $311.42B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: NetFlix Inc is far larger — about 573728.8× Nuwellis Inc's market cap, and NetFlix Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NFLX | NUWE | |
|---|---|---|
Market Cap | $311.42B | $542.80K |
Sector | Consumer Cyclical | Technology |
52-Week High | $126.33 | $220.50 |
52-Week Low | $67.60 | $1.42 |
Enterprise Value | $316.60B | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
Netflix (NFLX) trades at $74.79, up 0.88% on the day, showing resilience amid recent volatility. The stock exhibits strong fundamentals with robust revenue growth, expanding net income margins, and consistent earnings beats. Technical analysis indicates a bullish trend with key support at $74 and resistance at $77. Recent news highlights focus on the company's advertising business expansion and content performance.
The outlook for NFLX remains positive driven by advertising revenue growth and global subscriber expansion. Key risks include intense streaming competition and market sentiment shifts. Analyst consensus is strongly bullish with a $90.45 price target, suggesting significant upside potential from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →